Original Research
Accepted on 06 May 2024
Potential adverse events associated with sphingosine-1phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA Adverse Event Reporting System (FAERS) database
in Pharmacoepidemiology